✨ Environmental and Health Notices
15 OCTOBER 2009 NEW ZEALAND GAZETTE, No. 152
Management (National Environmental Standards Relating to Certain Air Pollutants, Dioxins, and Other Toxics) Regulations 2004.
(2) Any areas within the Hawke’s Bay region which are not covered by the separate airsheds described in this notice form a single airshed for that region.
- Revocation—The Hawke’s Bay Regional Airshed Notice 2005, published in the New Zealand Gazette, 25 August 2005, No. 141, page 3430, is revoked.
Dated at Wellington this 3rd day of October 2009.
HON DR NICK SMITH, Minister for the Environment.
Schedule
| Airshed Name | Description |
|---|---|
| 1. Napier | SO 391819 |
| 2. Hastings | SO 391819 |
| 3. Whirinaki | SO 391819 |
| 4. Awatoto | SO 391819 |
go8486
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Menitorix
Active Ingredients:
- Haemophilus influenzae Type b PRP 5μg/dose
- Neisseria meningitidis Group C 5μg/dose
- Tetanus toxoid 17.5μg/dose
Dosage Form: Powder for injection
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Product: Colgout
Active Ingredient: Colchicine 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Strides Arcolab Limited, Indlawadi Cross, Anekal Taluk, Bangalore, India
Dated this 8th day of October 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8491
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Glivec
Active Ingredient: Imatinib mesilate 59.75mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Dated this 8th day of October 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8492
Next Page →
✨ LLM interpretation of page content
Hawke’s Bay Regional Airshed Notice 2009
(continued from previous page)
Environment3 October 2009
Resource Management Act 1991, Airsheds, Hawke’s Bay, Napier, Hastings, Whirinaki, Awatoto
- HON DR NICK SMITH, Minister for the Environment
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare8 October 2009
Medicines Act 1981, New Medicines, Menitorix, Colgout, GlaxoSmithKline, Healthcare Logistics
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
🏥 Renewal of Provisional Consent to the Distribution of a Medicine
🏥 Health & Social Welfare8 October 2009
Medicines Act 1981, Provisional Consent, Glivec, Novartis, Imatinib mesilate
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
NZ Gazette 2009, No 152